Malaysia's insurance and takaful sectors are bracing for sustained double-digit growth in medical claims, as new figures reveal the healthcare financing landscape is shifting toward costlier private sector treatment. The total payout for medical claims climbed to RM13.5 billion last year, representing a 10.7 per cent jump from RM12.2 billion in 2024, according to joint findings released by the Life Insurance Association of Malaysia (LIAM), Malaysian Takaful Association (MTA), and General Insurance Association of Malaysia (PIAM). Behind these headline numbers lies a troubling trajectory: claims inflation of 12.28 per cent, signalling that the cost of healthcare protection is rising faster than general inflation and threatening the long-term viability of medical coverage for many Malaysians.
The breakdown of this 12.28 per cent inflation rate tells a crucial story about healthcare consumption patterns in Malaysia. Of this figure, 11.22 percentage points stemmed from an increase in the sheer volume of claims being filed, indicating that more insured individuals are accessing medical care than before. The remaining portion reflects genuine increases in the cost of treatment itself. This composition is vital for policymakers to understand: the problem is not merely that healthcare services have become more expensive, but that insured Malaysians are increasingly utilising medical facilities, likely driven by factors including demographic shifts, greater disease prevalence, improved insurance awareness, and employment-based coverage expansion.
Private healthcare facilities are emerging as the primary driver of this inflationary pressure. While public hospital claims declined by 14 per cent in costs year-on-year and represent just nine per cent of total claims submitted, private hospital charges rose 5.89 per cent and private day-care facilities saw a 2.3 per cent increase. This divergence underscores a growing wealth divide in healthcare access: those with insurance coverage are gravitating toward private providers offering shorter wait times and amenities, while public facilities bear the burden of uninsured and lower-income populations. For the insurance industry, this trend presents both operational challenges and sustainability questions, as private sector costs continue their upward march.
The acceleration in medical claims inflation has been dramatic when viewed over a longer timeframe. Between 2023 and 2025, average annual inflation in medical claims reached 13.63 per cent, more than 60 per cent higher than the approximately eight per cent rate recorded between 2013 and 2018. This trajectory signals a fundamental shift in Malaysia's healthcare economics and poses a critical challenge for takaful operators seeking to maintain fund sustainability for their participants. Mohd Radzuan Mohamed, chief executive of the MTA, highlighted this concern directly, noting that the escalating inflation rates threaten the financial health of protection schemes that many working Malaysians rely upon.
Industry leaders acknowledge that addressing this crisis requires coordination across multiple stakeholders. Mark O'Dell, LIAM's chief executive, anchored the industry's response in the World Bank's own analysis of Malaysia's Medical and Health Insurance/Takaful sector, which identified healthcare utilisation and service intensity as primary culprits behind rising costs. Rather than attempting to restrict access or curtail coverage, the sector is advocating for what it terms holistic, cross-sector collaboration involving policymakers, healthcare providers, insurers, takaful operators, and consumers themselves. This framing suggests that the solution lies not in rationing care but in fundamentally restructuring how healthcare is delivered and financed.
The insurance sector has also moved to implement concrete measures aimed at moderating the pace of claims growth. Cost-containment strategies already in motion include heightened enforcement against fraud, waste, and abuse; greater transparency regarding the true costs of medical procedures; and migration toward Diagnosis Related Group-based billing systems that tie payments to treatment outcomes rather than service volume. Additionally, the MediAsas plan, Malaysia's government-backed medical scheme introduced to provide affordable coverage for lower-income households, is expected to help distribute the burden more equitably across the system.
From a regional perspective, Malaysia's healthcare inflation experience resonates across Southeast Asia, where multiple nations grapple with rapidly ageing populations, rising non-communicable disease prevalence, and expanding insurance markets. The Malaysian case demonstrates how insurance penetration and private sector growth, while expanding access for wealthier segments, can trigger cost spirals that ultimately threaten system sustainability. Neighbouring countries watching Malaysia's trajectory may recognise familiar patterns in their own healthcare sectors, making the solutions adopted here potentially instructive for the wider region.
The sustainability question looms particularly large for takaful operators, whose participant bases often include middle and lower-middle income workers who depend on these schemes to fund treatment. A continuation of 12 to 13 per cent annual inflation means that real purchasing power of coverage diminishes over time unless premiums rise commensurately, ultimately pricing out the very populations these schemes were designed to serve. The industry's commitment to working with all stakeholders, while rhetorically sound, will be tested by whether concrete policy changes materialise to genuinely bend the cost curve.
For Malaysian consumers, the implications are immediate and consequential. Those with employer-sponsored medical coverage may see rising premiums in renewal cycles, while individuals purchasing individual policies face steeper cost barriers to entry. The shift toward private hospital utilisation, while reflecting individual preferences for perceived quality and convenience, collectively drives the system toward unsustainability. Consumers also bear some responsibility, the industry suggests, in making treatment decisions that account for appropriateness and necessity rather than convenience alone. This gentle accountability message reflects the industry's awareness that demand-side factors—including potential over-utilisation of unnecessary procedures in private settings—contribute meaningfully to inflation.
Looking ahead, the trajectory remains troubling absent significant intervention. The associations' joint statement affirms commitment to building an affordable, transparent, efficient and sustainable healthcare ecosystem, yet the 12.28 per cent inflation figure suggests current mechanisms are proving insufficient. The challenge facing Malaysian policymakers is substantial: how to maintain expanding access to quality medical protection while decelerating the cost inflation that threatens fund viability and coverage breadth. Whether the combination of fraud enforcement, billing reforms, cost transparency measures, and cross-sector collaboration proves adequate remains uncertain, but the urgency of the moment is undeniable.
